The global digital breast tomosynthesis (DBT) equipment market is poised for remarkable growth, projected to expand at a CAGR of 13.9% from 2023 to 2033. The market, valued at USD 2,594.4 million in 2023, is expected to reach an impressive USD 9,495.1 million by 2033. This surge is driven by the rising prevalence of breast cancer and the growing need for accurate breast cancer screening and diagnosis.
Digital breast tomosynthesis, also known as 3D breast imaging, is revolutionizing breast cancer detection by enhancing diagnostic accuracy, particularly for women with dense breast tissue. Unlike traditional 2D mammography, which may lead to false positives or missed diagnoses, DBT reconstructs multiple 2D images into a comprehensive 3D image, improving detection rates and reducing the need for unnecessary biopsies.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐍𝐨𝐰 : – https://www.futuremarketinsights.com/report-sample#5245502d47422d31323431
As breast cancer cases continue to rise globally, healthcare providers are prioritizing advanced imaging solutions to improve early detection and patient outcomes. The DBT market’s rapid expansion is further fueled by technological advancements in imaging and growing investments in healthcare infrastructure worldwide.
Key Takeaways:
Market Growth: Expected to reach USD 9.5 billion by 2033 at a CAGR of 13.9%
Rising Breast Cancer Cases: Increased demand for accurate and early screening technologies
Advantage Over 2D Mammography: Higher diagnostic accuracy with fewer false positives
Technology-Driven Expansion: Innovations in 3D imaging and AI-powered diagnostics propelling market growth
With DBT technology setting new standards in breast cancer screening, the market is expected to flourish over the next decade, ensuring enhanced patient care and early detection capabilities.
𝐀 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 – https://www.futuremarketinsights.com/reports/digital-breast-tomosynthesis-dbt-system-market
The global digital breast tomosynthesis (DBT) equipment market is projected to grow at a compound annual growth rate (CAGR) of 13.9% from 2023 to 2033, reaching an estimated value of USD 9,495.1 million by 2033. This growth is driven by several key factors:
𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡
- Increasing Prevalence of Breast Cancer:
- The rising incidence of breast cancer globally significantly contributes to the demand for advanced diagnostic tools like DBT. According to the World Health Organization, breast cancer is the most common cancer among women, with millions diagnosed each year.
- Enhanced Screening and Diagnostic Needs:
- There is a growing need for accurate and early detection of breast cancer, which drives the demand for DBT technology that provides more precise imaging capabilities compared to traditional mammography.
- Technological Advancements:
- Continuous innovations in DBT technology, including improved imaging techniques and integration with artificial intelligence (AI), enhance diagnostic accuracy and efficiency. These advancements are crucial in providing better patient outcomes and driving market growth.
- Lower False Positive Rates:
- DBT has a significantly lower chance of producing incorrect results compared to traditional 2D mammography. This high accuracy is particularly beneficial for diagnosing breast cancer in women with dense breast tissue, leading to increased adoption among healthcare providers.
- Growing Awareness and Education:
- Increased public awareness regarding the importance of early detection and the benefits of DBT is encouraging more women to undergo regular screenings, thereby boosting demand for DBT equipment.
- Regulatory Support and Recommendations:
- Endorsements from health organizations advocating for the use of advanced imaging techniques in breast cancer screening further support market growth. Regulatory approvals enhance the credibility and adoption of DBT technology.
- Rising Healthcare Expenditures:
- Increased healthcare spending on diagnostic imaging technologies by governments and private sectors facilitates the adoption of DBT systems in hospitals and clinics.
- Focus on Personalized Medicine:
- The shift towards personalized medicine emphasizes tailored approaches in healthcare, including enhanced imaging techniques that can lead to better treatment outcomes for patients diagnosed with breast cancer.
𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐜𝐨𝐩𝐞, 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬 – https://www.futuremarketinsights.com/industry-analysis/diagnostic-devices
𝐕𝐢𝐭𝐚𝐥 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐁𝐫𝐞𝐚𝐬𝐭 𝐓𝐨𝐦𝐨𝐬𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 (𝐃𝐁𝐓) 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬
- GE Healthcare
- Siemens Healthineers
- Hologic Inc.
- Canon Medical
- FUJIFILM Holdings Corporation
- General Electric Company
- Internazionale Medico Scientifica
- PLANMED OY
- Analogic Corporation
- Trivitron Healthcare
𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬
By Product:
- 3-D Equipment
- 3-D Upgradation
By End User:
- Hospitals
- Diagnostic Centres
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
